Form D · Other Health Care
Cx Precision Medicine, Inc.
Forth Worth, TX · CIK 0001681655
Offering snapshot reported Jun 26, 2024 · SEC filing
- Reported sold
- Yet to sell Offering amount: $4M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 26, 2024 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Dec 13, 2022 | Initial | $1,221,233 | No comparison | 25 | SEC filing |
| Aug 16, 2021 | Initial | $934,055 | No comparison | 12 | SEC filing |
| Aug 19, 2020 | Initial | $599,999 | No comparison | 13 | SEC filing |
| Aug 11, 2016 | Initial | $250,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-516935
Source: Form D, filed Jun 26, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Danguole Altman | Director, Executive |
| Darlene Boudreaux | Executive |
| Cameron Cushman | Director |
| Robert Ferguson | Director |
| Frank Gerome | Director, Executive |
| Jeff Keyser | Director |
| Donald Jeff Keyser | Director |
| Edward Lasater | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1660 S. University Dr., #1216
Forth Worth, TX, 76107
Forth Worth, TX, 76107